734 related articles for article (PubMed ID: 32700196)
1. Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.
Thomas X
Oncol Ther; 2019 Jun; 7(1):33-65. PubMed ID: 32700196
[TBL] [Abstract][Full Text] [Related]
2. Acute promyelocytic leukemia presenting as a paraspinal mass.
Shah NN; Stonecypher M; Gopal P; Luger S; Bagg A; Perl A
J Community Support Oncol; 2016 Mar; 14(3):126-9. PubMed ID: 27058871
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia: from highly fatal to highly curable.
Wang ZY; Chen Z
Blood; 2008 Mar; 111(5):2505-15. PubMed ID: 18299451
[TBL] [Abstract][Full Text] [Related]
5. [Acute promyelocytic leukemia: state-of-the-art management].
Asou N
Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
[TBL] [Abstract][Full Text] [Related]
6. History of Acute Promyelocytic Leukemia.
Sanz MA; Barragán E
Clin Hematol Int; 2021 Dec; 3(4):142-152. PubMed ID: 34938986
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
[TBL] [Abstract][Full Text] [Related]
8. [State-of-the-art treatment of acute promyelocytic leukemia].
Kiguchi T
Rinsho Ketsueki; 2018; 59(10):2007-2018. PubMed ID: 30305503
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia.
Yoo ES
Korean J Pediatr; 2011 Mar; 54(3):95-105. PubMed ID: 21738538
[TBL] [Abstract][Full Text] [Related]
10. Advances in therapies for acute promyelocytic leukemia.
Kamimura T; Miyamoto T; Harada M; Akashi K
Cancer Sci; 2011 Nov; 102(11):1929-37. PubMed ID: 21790894
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia: where did we start, where are we now, and the future.
Coombs CC; Tavakkoli M; Tallman MS
Blood Cancer J; 2015 Apr; 5(4):e304. PubMed ID: 25885425
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
13. Advances in Pediatric Acute Promyelocytic Leukemia.
Conneely SE; Stevens AM
Children (Basel); 2020 Feb; 7(2):. PubMed ID: 32024232
[TBL] [Abstract][Full Text] [Related]
14. AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.
Fatima M; Kakar SJ; Adnan F; Khan K; Mian AA; Khan D
BMC Cancer; 2021 Jun; 21(1):713. PubMed ID: 34140003
[TBL] [Abstract][Full Text] [Related]
15. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.
McCulloch D; Brown C; Iland H
Onco Targets Ther; 2017; 10():1585-1601. PubMed ID: 28352191
[TBL] [Abstract][Full Text] [Related]
17. What is the role of arsenic in newly diagnosed APL?
Tallman MS
Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
[TBL] [Abstract][Full Text] [Related]
18. Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse.
Gupta V; Shariff M; Bajwa R; Patel I; Ayyad HA; Levitt MJ; Mencel PJ; Hossain MA
World J Oncol; 2019 Jun; 10(3):153-156. PubMed ID: 31312283
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia current treatment algorithms.
Yilmaz M; Kantarjian H; Ravandi F
Blood Cancer J; 2021 Jun; 11(6):123. PubMed ID: 34193815
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment options for acute promyelocytic leukemia.
Ferrara F; Molica M; Bernardi M
Expert Opin Pharmacother; 2022 Jan; 23(1):117-127. PubMed ID: 34348549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
